About the Rhabdoid Tumor Session
Rhabdoid tumors are aggressive and rare cancers primarily affecting infants and young children. They most commonly occur in the kidneys, but can also develop in the brain, spinal cord, or other soft tissues. These tumors are characterized by their fast growth and tendency to spread to other parts of the body. Despite advances in cancer research, treatment options for rhabdoid tumors remain limited, and they often have poor outcomes.
Researchers are actively studying the genetic and molecular mechanisms underlying rhabdoid tumors to develop more effective treatments. Recent studies have identified specific genetic mutations associated with these tumors, providing potential targets for precision therapies. Immunotherapy, which harnesses the body's immune system to fight cancer, is also being explored as a promising treatment approach. Continued research efforts are crucial to improving outcomes for patients with rhabdoid tumors and advancing our understanding of this complex disease.
Topics Covered in Rhabdoid Tumor
SMARCB1 Loss
Intracranial Disease
Infant Kidney Tumors
Germline Predisposition
Epigenetic Therapy
Intensive Multimodal Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Rhabdoid Tumor Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Rhabdoid Tumor work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Rhabdoid Tumor research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Rhabdoid Tumor track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Rhabdoid Tumor Conference 2027 — FAQs
What is the Rhabdoid Tumor track at CIOC 2027?
The Rhabdoid Tumor track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Rhabdoid Tumor. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Rhabdoid Tumor sessions?
Cancer researchers and clinicians, educators and students with an interest in Rhabdoid Tumor are all welcome — whether presenting or attending.
Can I present my research in the Rhabdoid Tumor track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Rhabdoid Tumor sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Rhabdoid Tumor track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.